Added to YB: 2025-08-27
Pitch date: 2025-08-23
XTNT [bullish]
Xtant Medical Holdings, Inc.
+11.88%
current return
Author Info
Little Fish Capital shares stock pitches on micro/small cap stocks. Sign up for his free newsletter.
Company Info
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
Market Cap
$82.8M
Pitch Price
$0.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.55
P/E
-16.69
EV/Sales
0.88
Sector
Health Care Equipment and Supplies
Category
value
The Cast, Vol. 5 - Xtant Medical Holdings, Inc.
XTNT: Q2 +18% revenue growth, $3.6M net income, raised FY25 guidance to $131-$135M. Trading 0.95x FY25 revenue. Selling $19.2M non-core assets to focus on biologics w/ 68.6% gross margins. Risks: top-line reduction from sale, competitive medtech space, execution risk transitioning to pure biologics play.
Read full article (2 min)